In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: IDEX Corporation’s current price exceeds its PERT-weighted fair value by 10.5%, indicating potential overvaluation with high downside risk reflected in 75% of Monte Carlo scenarios. Valuations vary widely due to volatility and a broad WACC/growth range, while financial health shows strong liquidity but weak growth. The disparity between valuation methods suggests cautious interpretation of its growth prospects.